全球晶片器官市场规模、份额、趋势和成长分析报告（2026-2034）

预计晶片器官市场将从 2025 年的 2.2865 亿美元成长到 2034 年的 35.6295 亿美元，2026 年至 2034 年的复合年增长率为 35.68%。

受生物医学研究和药物开发进展的推动，全球器官晶片市场正经历快速成长。器官晶片技术可在微流体装置上模拟人体器官功能，进而达到更精准的临床前试验。对动物试验替代方案和更完善的药物安全性评估的需求不断增长，也推动了市场扩张。生技和製药领域研发投入的增加，进一步加速了技术创新。

关键成长要素包括对个人化医疗和精准药物筛检的日益重视。製药公司正在采用晶片器官平台来缩短研发时间并降低成本。微加工和生物材料技术的进步正在提升设备的性能。学术机构和研究组织也在投资这项技术，用于疾病建模和毒性测试。

展望未来，生物技术公司与研究机构之间日益增强的商业化和合作预计将对市场产生积极影响。在癌症研究和再生医学领域的应用拓展将创造新的机会。多器官晶片系统的持续创新将提高预测准确性。随着对符合伦理且高效的药物测试方法的需求不断增长，全球器官晶片市场预计将迎来强劲的长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球晶片器官市场：依产品和服务划分

• 市场分析、洞察与预测
• 产品
• 服务

第五章：全球晶片器官市场：依应用划分

• 市场分析、洞察与预测
• 药物发现
• 毒理学调查
• 其他的

第六章：全球晶片器官市场：依最终用途划分

• 市场分析、洞察与预测
• 学术研究机构
• 製药和生物技术公司
• 其他的

第七章：全球晶片器官市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Emulate Inc
  • MIMETAS BV
  • Valo Health
  • Nortis Inc
  • AxoSim Inc
  • BICO Group AB（The Bio Convergence Company）
  • CN Bio Innovations Ltd
  • SynVivo Inc
  • The Charles Stark Draper Laboratory Inc
  • AlveoliX AG

The Organ On A Chip Market size is expected to reach USD 3562.95 Million in 2034 from USD 228.65 Million (2025) growing at a CAGR of 35.68% during 2026-2034.

The Global Organ On A Chip Market is experiencing rapid growth driven by advancements in biomedical research and drug development. Organ-on-a-chip technology replicates human organ functions on microfluidic devices, enabling more accurate preclinical testing. Increasing demand for alternatives to animal testing and improved drug safety evaluation is supporting market expansion. Rising research funding in biotechnology and pharmaceutical sectors is further accelerating innovation.

Key growth drivers include the growing focus on personalized medicine and precision drug screening. Pharmaceutical companies are adopting organ-on-a-chip platforms to reduce development timelines and costs. Technological advancements in microfabrication and biomaterials are enhancing device performance. Academic institutions and research organizations are also investing in this technology for disease modeling and toxicity testing.

Looking ahead, the market is expected to benefit from increased commercialization and collaboration between biotech firms and research institutions. Expanding applications in cancer research and regenerative medicine will create new opportunities. Continuous innovation in multi-organ chip systems will improve predictive accuracy. As demand for ethical and efficient drug testing methods rises, the Global Organ On A Chip Market is poised for strong long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Service

• Products
• Services

By Application

• Drug Discovery
• Toxicology Research
• Others

By End Use

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

COMPANIES PROFILED

• Emulate Inc, MIMETAS BV, Valo Health, Nortis Inc, AxoSim Inc, BICO Group AB The Bio Convergence Company, CN Bio Innovations Ltd, SynVivo Inc, The Charles Stark Draper Laboratory Inc, AlveoliX AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORGAN ON A CHIP MARKET: BY PRODUCT AND SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Service
• 4.2. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORGAN ON A CHIP MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Toxicology Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORGAN ON A CHIP MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORGAN ON A CHIP MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product And Service
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product And Service
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product And Service
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product And Service
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product And Service
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ORGAN ON A CHIP INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Emulate Inc
  • 9.2.2 MIMETAS B.V
  • 9.2.3 Valo Health
  • 9.2.4 Nortis Inc
  • 9.2.5 AxoSim Inc
  • 9.2.6 BICO Group AB (The Bio Convergence Company)
  • 9.2.7 CN Bio Innovations Ltd
  • 9.2.8 SynVivo Inc
  • 9.2.9 The Charles Stark Draper Laboratory Inc
  • 9.2.10 AlveoliX AG